Evidence map›Paper›PMID 25553142›Full record

ArticleThe open virology journal2014

Disease caused by rotavirus infection.

Che-Liang Lin, Shou-Chien Chen, Shyun-Yeu Liu, Kow-Tong Chen

Open access · hybridAbstract read
In one paragraph

Article in The open virology journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Microorganisms · 2021
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Seroprevalence ofVeterinary world · 2016
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Che-Liang LinInternal Medicine Chest Division, Chi-Mei Medical Center, Liouying, Tainan, Taiwan.
Shou-Chien ChenDepartment of Family Medicine, Da-Chien General Hospital, Miaoli, Taiwan ; General Education Center, Ta Tung University, Taipei, Taiwan.
Shyun-Yeu LiuChi-Mei Medical Center, Tainan, Taiwan.
Kow-Tong ChenDepartment of Occupational Medicine, Tainan Municipal Hospital, Tainan, Taiwan ; Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Chi Mei Medical Center · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although rotavirus vaccines are available, rotaviruses remain the major cause of childhood diarrheal disease worldwide. The Rotarix (GlaxoSmithKline Biologicals Rixensart, Belgium) and RotaTeq (Merck and Co., Inc. Whitehouse Station, New Jersey, USA) vaccines are effective for reducing the morbidity and mortality of rotavirus infection. This article aims to assess the epidemiology of rotaviral gastroenteritis and the efficacy and effectiveness of licensed rotavirus vaccines. This review concludes by presenting challenges in the field that require further exploration by and perspectives from basic and translational research in the future.

Indexed as

Effectivenessefficacyrotavirusrotavirus vaccine.

Identifiers

PMID25553142
PMCPMC4279035
OpenAlexW2123305593

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.